Ryse Health, a Virginia-based health-tech startup, announced that it has secured a $3.4M in a Seed funding round led by W Health Venture.
Other investors, including LifeBridge Health, Healthworx, Shantanu Agrawal, MD, John Wray, and Kelly Close, participated in the round.
Type 2 diabetes
Diabetes Mellitus affects the way that blood sugar (glucose) is processed and handled in your body. Type 2 diabetes mellitus (otherwise known as DM2 or diabetes type 2) is the most common type of diabetes affecting about 1 in 10 people in the United States. All ages can develop type 2 diabetes, but it is most common in adults over 45 years old.
Fortunately, type 2 diabetes is treatable. With type 2 diabetes, the goal is to keep the blood sugar levels from going too high or too low.
Most people use finger pricks to check their blood sugar, but continuous glucose monitors are a more comprehensive way to measure blood sugar with less work. And that’s what Ryse Health does.
Ryse Health works with users to build a personalised plan to beat diabetes and feel better.
How does Ryse Health help?
Founded by Erin Kane and Richard Gurley, Ryse Health provides
tech-enabled office-based and virtual care to patients with type 2 diabetes.
Ryse Health’s dedicated care team provides day-to-day support, analytics, and coaching to ensure continued success in type 2 diabetes management. Patients also will get to connect with peers on the journey.
Their care team comprises health coaches, endocrinologists, and a broad care team of registered dieticians (RDs), certified diabetes care and education specialists (CDCESs), and licensed clinical social workers (LCSWs) to help patients navigate the psychosocial barriers to overcoming chronic disease.
“Traditionally, patients get healthcare once a year or a few times a year, while they are making decisions about and struggling with chronic conditions every single day,” says Dr. Kane.
“Part of what I love about our model is that we integrate into our patients’ lives so we can provide more frequent touchpoints and help along the journey, truly helping patients to keep up the momentum and keep pushing things in the right direction,” he adds.
What does it offer?
The company provides expert coaching that is tailored to users’ unique preferences and data points.
The US company’s technology platform includes a Continuous Glucose Monitor (CGM) and a custom app to synthesise data, support self-management, and facilitate smooth communication.
The continuous glucose monitor provides real-time data on blood glucose levels with no fingersticks.
Ryse Health says it has seen early clinical results, including a two-point drop in patients’ A1C numbers for patients starting at an A1c of greater than 8% and a 36% decrease in elevated blood sugars for all patients after the first 60 days of the program.
“We are so gratified by the initial results we’re seeing,” says Dr. Kane. “We’re hearing from patients that they have more energy and feel better than they have in a long time. People with diabetes deserve care that is compassionate, seamless, and effective, and that’s what we’re delivering. My team and I look forward to growing and helping thousands of people improve their health and live happier longer lives.”
At present, the company operates in Arlington ad Baltimore.
Investor
Based out of Boston, W Health Ventures invests in digital health companies that are transforming healthcare delivery. The VC designs, build, and grows healthcare companies that address critical unmet healthcare needs and simplify the experience for patients and providers.
